Autonomic nervous system dysfunction in Parkinson’s disease

被引:82
作者
Theresa A. Zesiewicz
Matthew J. Baker
Mervat Wahba
Robert A. Hauser
机构
[1] Parkinson’s Disease and Movement Disorders Center,
关键词
Levodopa; Sexual Dysfunction; Orthostatic Hypotension; Autonomic Dysfunction; Selegiline;
D O I
10.1007/s11940-003-0005-0
中图分类号
学科分类号
摘要
Autonomic nervous system (ANS) dysfunction is common in Parkinson’s disease (PD), affects 70% to 80% of patients, and causes significant morbidity and discomfort. Autonomic nervous system dysfunction symptoms in PD include sexual dysfunction, swallowing and gastrointestinal disorders, bowel and bladder abnormalities, sleep disturbances, and derangements of cardiovascular regulation, particularly, orthostatic hypotension. Autonomic nervous system dysfunction in PD may be caused by an underlying degenerative process that affects the autonomic ganglia, brainstem nuclei, and hypothalamic nuclei. Anti-parkinsonian medications can cause or worsen symptoms of ANS dysfunction. The care of a PD patient with ANS dysfunction relies on its recognition and directed treatment, including coordinated care between the neurologist and appropriate subspecialist. Pharmacotherapy may be useful to treat orthostasis, gastrointestinal, urinary, and sexual dysfunction.
引用
收藏
页码:149 / 160
页数:11
相关论文
共 247 条
[1]
Turkka J(1997)Selegiline diminishes cardiovascular autonomic responses in Parkinson’s disease Neurology 48 662-667
[2]
Suominen K(1986)Autonomic disorders in idiopathic Parkinsonism J Neural Transm 22 149-161
[3]
Tolonen U(1971)Neurogenic bladder in Parkinson’s disease: effect of thalamotomy J Neurosurg 34 27-27
[4]
Martignoni E(1992)Autonomic dysfunction in men with Parkinson’s disease Eur Neurol 32 134-140
[5]
Micieli G(2000)Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson’s disease Urology 56 250-254
[6]
Cavallini A(1983)Neurourologic findings in Parkinson’s disease J Urol 129 80-83
[7]
Porter RW(1967)Extrapyramidal inhibition of the urinary bladder Brain Res 4 301-301
[8]
Bors E(1976)Cystometric, sphincter and electromyelographic abnormalities in Parkinson’s disease J Urol 116 75-78
[9]
Singer C(1985)Management of urinary incontinence in the elderly N Engl J Med 313 800-805
[10]
Weiner WJ(1995)Oxybutynin: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability Drugs Aging 6 243-262